LIVIVO - Search results -

Search results

Result 1 - 10 of total 16

Search options

Article ; Online: Chapter 5--Aspergillosis: from diagnosis to treatment.

Sales, Maria da Penha Uchoa

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

2010 Volume 35, Issue 12, Page(s) 1238–1244

Abstract: Aspergillosis is a multifaceted disease whose clinical manifestations (allergic, saprophytic and invasive forms) are determined by the host immune response. Allergic bronchopulmonary aspergillosis is characterized by corticosteroid-dependent asthma, ... ...

Abstract	Aspergillosis is a multifaceted disease whose clinical manifestations (allergic, saprophytic and invasive forms) are determined by the host immune response. Allergic bronchopulmonary aspergillosis is characterized by corticosteroid-dependent asthma, fever, hemoptysis and destruction of the airways, which can evolve to fibrosis with honeycombing. The treatment consists of the combined use of a corticosteroid and itraconazole. Invasive pulmonary aspergillosis, which has a worse prognosis, is diagnosed based on histopathological documentation and positive culture of a sterile specimen. The treatment response obtained with voriconazole is better, in terms of survival and safety, than that obtained with amphotericin B. In patients with chronic pulmonary disease who are mildly immunocompromised, chronic necrotizing pulmonary aspergillosis causes progressive destruction of the lung. Such patients are treated with oral itraconazole. Chronic cavitary pulmonary aspergillosis causes multiple cavities, with or without aspergilloma, accompanied by pulmonary and systemic symptoms. In patients with chronic pulmonary disease, the aspergilloma is characterized by chronic productive cough and hemoptysis, together with a cavity containing a rounded, sometimes mobile, mass separated from the cavity wall by airspace. Surgical resection is the definitive treatment for both types of aspergillosis. Triazole fungicides provide long-term treatment benefits with minimal risk.
MeSH term(s)	Aspergillosis/classification ; Aspergillosis/diagnosis ; Aspergillosis/drug therapy ; Humans
Language	Portuguese
Publishing date	2010-02-01
Publishing country	Brazil
Document type	Journal Article ; Review
ZDB-ID	2223157-2
ISSN	1806-3756 ; 1806-3713
ISSN (online)	1806-3756
ISSN	1806-3713
DOI	10.1590/s1806-37132009001200012
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Capítulo 5 - Aspergilose

Maria da Penha Uchoa Sales

Jornal Brasileiro de Pneumologia, Vol 35, Iss 12, Pp 1238-

do diagnóstico ao tratamento Chapter 5 - Aspergillosis: from diagnosis to treatment

2009 Volume 1244

Abstract: ... broncopulmonar alérgica caracteriza-se por asma corticoide dependente, febre, hemoptise e destruição da via aérea ... que pode progredir para fibrose com faveolamento. O tratamento consiste da associação de ... separada da parede por espaço aéreo. A ressecção cirúrgica é o tratamento definitivo para ambas ...

Abstract	A aspergilose é uma doença multifacetada cujas manifestações clínicas são determinadas pela resposta imune do hospedeiro; podem se apresentar de forma alérgica, saprofítica ou invasiva. A aspergilose broncopulmonar alérgica caracteriza-se por asma corticoide dependente, febre, hemoptise e destruição da via aérea, que pode progredir para fibrose com faveolamento. O tratamento consiste da associação de corticosteroide e itraconazol. A aspergilose pulmonar invasiva requer documentação histopatológica e cultura positiva de material estéril para o diagnóstico. Possui pior prognóstico. O voriconazol apresenta melhor resposta terapêutica, proporcionando maior sobrevida e segurança do que a anfotericina B. A aspergilose pulmonar necrotizante crônica causa destruição progressiva do pulmão em pacientes com doença pulmonar crônica e leve grau de imunossupressão. O tratamento é realizado com itraconazol oral. A aspergilose pulmonar cavitária crônica causa múltiplas cavidades, contendo ou não aspergiloma, associadas a sintomas pulmonares e sistêmicos. O aspergiloma é caracterizado por tosse produtiva crônica e hemoptise em portadores de doença pulmonar crônica, associados a uma cavidade contendo massa arredondada, às vezes móvel, e separada da parede por espaço aéreo. A ressecção cirúrgica é o tratamento definitivo para ambas. Antifúngicos triazólicos promovem beneficio terapêutico a longo prazo com risco mínimo. Aspergillosis is a multifaceted disease whose clinical manifestations (allergic, saprophytic and invasive forms) are determined by the host immune response. Allergic bronchopulmonary aspergillosis is characterized by corticosteroid-dependent asthma, fever, hemoptysis and destruction of the airways, which can evolve to fibrosis with honeycombing. The treatment consists of the combined use of a corticosteroid and itraconazole. Invasive pulmonary aspergillosis, which has a worse prognosis, is diagnosed based on histopathological documentation and positive culture of a sterile specimen. The treatment response obtained with voriconazole is better, in terms of survival and safety, than that obtained with amphotericin B. In patients with chronic pulmonary disease who are mildly immunocompromised, chronic necrotizing pulmonary aspergillosis causes progressive destruction of the lung. Such patients are treated with oral itraconazole. Chronic cavitary pulmonary aspergillosis causes multiple cavities, with or without aspergilloma, accompanied by pulmonary and systemic symptoms. In patients with chronic pulmonary disease, the aspergilloma is characterized by chronic productive cough and hemoptysis, together with a cavity containing a rounded, sometimes mobile, mass separated from the cavity wall by airspace. Surgical resection is the definitive treatment for both types of aspergillosis. Triazole fungicides provide long-term treatment benefits with minimal risk.
Keywords	Aspergilose ; Aspergilose pulmonar ; Pneumopatias fúngicas ; Aspergillosis ; Pulmonary aspergillosis ; Lung diseases ; fungal ; Diseases of the respiratory system ; RC705-779 ; Specialties of internal medicine ; RC581-951 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Internal medicine ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
Language	Portuguese
Publishing date	2009-12-01T00:00:00Z
Publisher	Sociedade Brasileira de Pneumologia e Tisiologia
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Smoking control: challenges and achievements.

Silva, Luiz Carlos Corrêa da / Araújo, Alberto José de / Queiroz, Ângela Maria Dias de / Sales, Maria da Penha Uchoa / Castellano, Maria Vera Cruz de Oliveira

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

2016 Volume 42, Issue 4, Page(s) 290–298

Abstract: ... por isso, precisa ter a máxima atenção e ser muito mais enfocado por todos os profissionais da saúde ... controlada sob o ponto de vista da saúde pública. Já se observam modificações do comportamento da sociedade ... destaque na medida em que se envolvam com o tratamento dos fumantes, a aplicação da lei antifumo e ...

Abstract	Smoking is the most preventable and controllable health risk. Therefore, all health care professionals should give their utmost attention to and be more focused on the problem of smoking. Tobacco is a highly profitable product, because of its large-scale production and great number of consumers. Smoking control policies and treatment resources for smoking cessation have advanced in recent years, showing highly satisfactory results, particularly in Brazil. However, there is yet a long way to go before smoking can be considered a controlled disease from a public health standpoint. We can already perceive that the behavior of our society regarding smoking is changing, albeit slowly. Therefore, pulmonologists have a very promising area in which to work with their patients and the general population. We must act with greater impetus in support of health care policies and social living standards that directly contribute to improving health and quality of life. In this respect, pulmonologists can play a greater role as they get more involved in treating smokers, strengthening anti-smoking laws, and demanding health care policies related to lung diseases. RESUMO O tabagismo é o fator de risco mais prevenível e controlável em saúde e, por isso, precisa ter a máxima atenção e ser muito mais enfocado por todos os profissionais da saúde. O tabaco é um produto de alta rentabilidade pela sua grande produção e pelo elevado número de consumidores. As políticas de controle e os recursos terapêuticos para o tabagismo avançaram muito nos últimos anos e têm mostrado resultados altamente satisfatórios, particularmente no Brasil. Entretanto, ainda resta um longo caminho a ser percorrido para que se possa considerar o tabagismo como uma doença controlada sob o ponto de vista da saúde pública. Já se observam modificações do comportamento da sociedade com relação ao tabagismo, mas ainda em escala muito lenta, de modo que os pneumologistas têm nesse setor um campo muito promissor para atuar junto a seus pacientes e a população em geral. É preciso atuar com maior ímpeto em prol das políticas de saúde e das normas de convívio social que contribuem diretamente para melhorar a saúde e a vida. Nesse aspecto, os pneumologistas podem ter um papel de maior destaque na medida em que se envolvam com o tratamento dos fumantes, a aplicação da lei antifumo e as políticas de saúde relacionadas às doenças respiratórias.
MeSH term(s)	Brazil ; Health Policy ; Humans ; Pulmonary Disease, Chronic Obstructive/etiology ; Pulmonary Disease, Chronic Obstructive/prevention & control ; Pulmonologists ; Smoking/adverse effects ; Smoking/legislation & jurisprudence ; Smoking Cessation/legislation & jurisprudence ; Smoking Prevention
Language	Portuguese
Publishing date	2016-07
Publishing country	Brazil
Document type	Journal Article ; Review
ZDB-ID	2223157-2
ISSN	1806-3756 ; 1806-3713
ISSN (online)	1806-3756
ISSN	1806-3713
DOI	10.1590/S1806-37562016000000145
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Update on the approach to smoking in patients with respiratory diseases.

Sales, Maria Penha Uchoa / Araújo, Alberto José de / Chatkin, José Miguel / Godoy, Irma de / Pereira, Luiz Fernando Ferreira / Castellano, Maria Vera Cruz de Oliveira / Tanni, Suzana Erico / Almeida, Adriana Ávila de / Chatkin, Gustavo / Silva, Luiz Carlos Côrrea da / Gonçalves, Cristina Maria Cantarino / Botelho, Clóvis / Santos, Ubiratan Paula / Viegas, Carlos Alberto de Assis / Sestelo, Maristela Rodrigues / Meireles, Ricardo Henrique Sampaio / Correa, Paulo César Rodrigues Pinto / Oliveira, Maria Eunice Moraes de / Reichert, Jonatas /

Lima, Mariana Silva / Silva, Celso Antonio Rodrigues da

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

2019 Volume 45, Issue 3, Page(s) e20180314

Abstract: Smoking is the leading cause of respiratory disease (RD). The harmful effects of smoking on the respiratory system begin in utero and influence immune responses throughout childhood and adult life. In comparison with "healthy" smokers, smokers with RD ... ...

Abstract	Smoking is the leading cause of respiratory disease (RD). The harmful effects of smoking on the respiratory system begin in utero and influence immune responses throughout childhood and adult life. In comparison with "healthy" smokers, smokers with RD have peculiarities that can impede smoking cessation, such as a higher level of nicotine dependence; nicotine withdrawal; higher levels of exhaled carbon monoxide; low motivation and low self-efficacy; greater concern about weight gain; and a high prevalence of anxiety and depression. In addition, they require more intensive, prolonged treatment. It is always necessary to educate such individuals about the fact that quitting smoking is the only measure that will reduce the progression of RD and improve their quality of life, regardless of the duration and severity of the disease. Physicians should always offer smoking cessation treatment. Outpatient or inpatient smoking cessation treatment should be multidisciplinary, based on behavioral interventions and pharmacotherapy. It will thus be more effective and cost-effective, doubling the chances of success.
MeSH term(s)	Humans ; Lung Neoplasms/etiology ; Lung Neoplasms/therapy ; Pulmonary Disease, Chronic Obstructive/etiology ; Pulmonary Disease, Chronic Obstructive/therapy ; Respiratory Tract Diseases/etiology ; Respiratory Tract Diseases/therapy ; Risk Factors ; Smoking/adverse effects ; Smoking Cessation ; Tobacco Use Disorder/complications ; Tobacco Use Disorder/therapy ; Tuberculosis, Pulmonary/etiology ; Tuberculosis, Pulmonary/therapy
Language	Portuguese
Publishing date	2019-06-27
Publishing country	Brazil
Document type	Journal Article ; Review
ZDB-ID	2223157-2
ISSN	1806-3756 ; 1806-3713
ISSN (online)	1806-3756
ISSN	1806-3713
DOI	10.1590/1806-3713/e20180314
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Invasive pulmonary aspergillosis due to a mixed infection caused by Aspergillus flavus and Aspergillus fumigatus.

Orzechowski Xavier, Melissa / Pasqualotto, Alessandro Comarú / Uchoa Sales, Maria Da Penha / Bittencourt Severo, Cecília / Peixoto Camargo, José J / Severo, Luiz Carlos

Revista iberoamericana de micologia

2008 Volume 25, Issue 3, Page(s) 176–178

Abstract: Invasive pulmonary aspergillosis is typically caused by a single Aspergillus species, most frequently Aspergillus fumigatus. Here we report that a lung transplant recipient developed invasive aspergillosis due to a mixed infection caused by Aspergillus ... ...

Abstract	Invasive pulmonary aspergillosis is typically caused by a single Aspergillus species, most frequently Aspergillus fumigatus. Here we report that a lung transplant recipient developed invasive aspergillosis due to a mixed infection caused by Aspergillus flavus and A. fumigatus. The implications for this unusual finding are discussed.
MeSH term(s)	Adult ; Aspergillus flavus ; Aspergillus fumigatus ; Fatal Outcome ; Humans ; Invasive Pulmonary Aspergillosis/microbiology ; Male
Language	English
Publishing date	2008-09-01
Publishing country	Spain
Document type	Case Reports ; Journal Article
ISSN	1130-1406
ISSN	1130-1406
DOI	10.1016/s1130-1406(08)70041-x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Recommendations for the pharmacological treatment of COPD: questions and answers.

Fernandes, Frederico Leon Arrabal / Cukier, Alberto / Camelier, Aquiles Assunção / Fritscher, Carlos Cezar / Costa, Cláudia Henrique da / Pereira, Eanes Delgado Barros / Godoy, Irma / Cançado, José Eduardo Delfini / Romaldini, José Gustavo / Chatkin, Jose Miguel / Jardim, José Roberto / Rabahi, Marcelo Fouad / Nucci, Maria Cecília Nieves Maiorano de / Sales, Maria da Penha Uchoa / Castellano, Maria Vera Cruz de Oliveira / Aidé, Miguel Abidon / Teixeira, Paulo José Zimermann / Maciel, Renato / Corrêa, Ricardo de Amorim /

Stirbulov, Roberto / Athanazio, Rodrigo Abensur / Russo, Rodrigo / Minamoto, Suzana Tanni / Lundgren, Fernando Luiz Cavalcanti

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

2018 Volume 43, Issue 4, Page(s) 290–301

Abstract: The treatment of COPD has become increasingly effective. Measures that range from behavioral changes, reduction in exposure to risk factors, education about the disease and its course, rehabilitation, oxygen therapy, management of comorbidities, and ... ...

Abstract	The treatment of COPD has become increasingly effective. Measures that range from behavioral changes, reduction in exposure to risk factors, education about the disease and its course, rehabilitation, oxygen therapy, management of comorbidities, and surgical and pharmacological treatments to end-of-life care allow health professionals to provide a personalized and effective therapy. The pharmacological treatment of COPD is one of the cornerstones of COPD management, and there have been many advances in this area in recent years. Given the greater availability of drugs and therapeutic combinations, it has become increasingly challenging to know the indications for, limitations of, and potential risks and benefits of each treatment modality. In order to critically evaluate recent evidence and systematize the major questions regarding the pharmacological treatment of COPD, 24 specialists from all over Brazil gathered to develop the present recommendations. A visual guide was developed for the classification and treatment of COPD, both of which were adapted to fit the situation in Brazil. Ten questions were selected on the basis of their relevance in clinical practice. They address the classification, definitions, treatment, and evidence available for each drug or drug combination. Each question was answered by two specialists, and then the answers were consolidated in two phases: review and consensus by all participants. The questions answered are practical questions and help select from among the many options the best treatment for each patient and his/her peculiarities.
MeSH term(s)	Disease Management ; Humans ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Severity of Illness Index ; Surveys and Questionnaires
Language	Portuguese
Publishing date	2018-01-24
Publishing country	Brazil
Document type	Journal Article ; Review
ZDB-ID	2223157-2
ISSN	1806-3756 ; 1806-3713
ISSN (online)	1806-3756
ISSN	1806-3713
DOI	10.1590/S1806-37562017000000153
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Smoking cessation guidelines--2008.

Reichert, Jonatas / Araújo, Alberto José de / Gonçalves, Cristina Maria Cantarino / Godoy, Irma / Chatkin, José Miguel / Sales, Maria da Penha Uchoa / Santos, Sergio Ricardo Rodrigues de Almeida

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

2008 Volume 34, Issue 10, Page(s) 845–880

Abstract: These guidelines are an up-to-date and comprehensive tool to aid health professionals in treating smokers, recommending measures and strategies for managing each case based on clinical evidence. Written in a simplified and objective manner, the text is ... ...

Abstract	These guidelines are an up-to-date and comprehensive tool to aid health professionals in treating smokers, recommending measures and strategies for managing each case based on clinical evidence. Written in a simplified and objective manner, the text is divided into two principal sections: Evaluation and Treatment. The sections both present comments on and levels of evidence represented by the references cited, as well as some proposals for the reduction of damage and for intervening in specific and still poorly explored situations, such as relapse, passive smoking, physician smoking, and tobacco use in specific environments.
MeSH term(s)	Adolescent ; Adult ; Aged ; Child ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Motivation ; Pregnancy ; Recurrence ; Severity of Illness Index ; Smoking/pathology ; Smoking/psychology ; Smoking/therapy ; Smoking Cessation/methods ; Smoking Cessation/psychology ; Smoking Cessation/statistics & numerical data ; Tobacco Use Disorder/pathology ; Tobacco Use Disorder/psychology ; Tobacco Use Disorder/therapy ; Young Adult
Language	Portuguese
Publishing date	2008-10-22
Publishing country	Brazil
Document type	Guideline ; Journal Article ; Review
ZDB-ID	2223157-2
ISSN	1806-3756 ; 1806-3713
ISSN (online)	1806-3756
ISSN	1806-3713
DOI	10.1590/s1806-37132008001000014
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient: case report.

Xavier, Melissa Orzechowski / Sales, Maria da Penha Uchoa / Camargo, José de Jesus Peixoto / Pasqualotto, Alessandro Comarú / Severo, Luiz Carlos

Revista da Sociedade Brasileira de Medicina Tropical

2008 Volume 41, Issue 2, Page(s) 200–201

Abstract: A case of invasive aspergillosis caused by Aspergillus niger in a lung transplant recipient is described. The patient presented hyperglycemia starting postoperatively, with other complications such as cytomegalovirus infection. The associated ... ...

Abstract	A case of invasive aspergillosis caused by Aspergillus niger in a lung transplant recipient is described. The patient presented hyperglycemia starting postoperatively, with other complications such as cytomegalovirus infection. The associated predisposing factors and other implications are discussed. Aspergillus niger seems to be a fungal species of low virulence that requires the presence of a severely immunosuppressed host to cause invasive disease.
MeSH term(s)	Aspergillosis/diagnosis ; Aspergillosis/etiology ; Aspergillus niger/isolation & purification ; Bronchitis/diagnosis ; Bronchitis/microbiology ; Fatal Outcome ; Female ; Humans ; Immunocompromised Host ; Lung Diseases, Fungal/diagnosis ; Lung Diseases, Fungal/microbiology ; Lung Transplantation/adverse effects ; Middle Aged ; Tracheitis/diagnosis ; Tracheitis/microbiology
Language	English
Publishing date	2008-06-03
Publishing country	Brazil
Document type	Case Reports ; Journal Article
ZDB-ID	1038126-0
ISSN	1678-9849 ; 0037-8682
ISSN (online)	1678-9849
ISSN	0037-8682
DOI	10.1590/s0037-86822008000200014
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2726: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient

Melissa Orzechowski Xavier / Maria da Penha Uchoa Sales / José de Jesus Peixoto Camargo / Alessandro Comarú Pasqualotto / Luiz Carlos Severo

Revista da Sociedade Brasileira de Medicina Tropical, Vol 41, Iss 2, Pp 200-

case report Aspergillus niger causando traqueobronquite e aspergilose pulmonar invasiva em transplantado de pulmão: relato de caso

2008 Volume 201

Abstract	A case of invasive aspergillosis caused by Aspergillus niger in a lung transplant recipient is described. The patient presented hyperglycemia starting postoperatively, with other complications such as cytomegalovirus infection. The associated predisposing factors and other implications are discussed. Aspergillus niger seems to be a fungal species of low virulence that requires the presence of a severely immunosuppressed host to cause invasive disease. Descreve-se um caso de aspergilose invasiva causada por Aspergillus niger em um paciente transplantado de pulmão com quadros hiperglicêmicos desde o pós-operatório e outras complicações como infecção por citomegalovírus. Os fatores predisponentes associados e outras implicações são discutidos. Aspergillus niger parece ser uma espécie fúngica de baixa virulência, necessitando a presença de um hospedeiro gravemente imunodeprimido para causar doença invasiva.
Keywords	Aspergilose ; Traqueobronquite ; Aspergillus niger ; Transplante pulmonar ; Aspergillosis ; Tracheobronchitis ; Lung transplantation ; Arctic medicine. Tropical medicine ; RC955-962
Language	English
Publishing date	2008-04-01T00:00:00Z
Publisher	Sociedade Brasileira de Medicina Tropical (SBMT)
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Diretrizes para cessação do tabagismo - 2008 Smoking cessation guidelines - 2008

Jonatas Reichert / Alberto José de Araújo / Cristina Maria Cantarino Gonçalves / Irma Godoy / José Miguel Chatkin / Maria da Penha Uchoa Sales / Sergio Ricardo Rodrigues de Almeida Santos

Jornal Brasileiro de Pneumologia, Vol 34, Iss 10, Pp 845-

2008 Volume 880

Abstract: Estas diretrizes constituem uma ferramenta atualizada e abrangente para auxiliar o profissional de saúde na abordagem do tabagista, recomendando atitudes baseadas em evidências clínicas como a melhor forma de conduzir cada caso. De forma reduzida e mais ... ...

Abstract	Estas diretrizes constituem uma ferramenta atualizada e abrangente para auxiliar o profissional de saúde na abordagem do tabagista, recomendando atitudes baseadas em evidências clínicas como a melhor forma de conduzir cada caso. De forma reduzida e mais objetiva possível, o texto final foi agrupado em dois grandes itens: Avaliação e Tratamento. Os dois itens apresentam comentários e níveis de recomendação das referências utilizadas, bem como algumas propostas de abordagem, como por exemplo, redução de danos, em situações específicas ainda pouco exploradas, como recaídas, tabagismo passivo, tabagismo na categoria médica e uso de tabaco em ambientes específicos. These guidelines are an up-to-date and comprehensive tool to aid health professionals in treating smokers, recommending measures and strategies for managing each case based on clinical evidence. Written in a simplified and objective manner, the text is divided into two principal sections: Evaluation and Treatment. The sections both present comments on and levels of evidence represented by the references cited, as well as some proposals for the reduction of damage and for intervening in specific and still poorly explored situations, such as relapse, passive smoking, physician smoking, and tobacco use in specific environments.
Keywords	Tabagismo ; Abandono do hábito de fumar ; Guia ; Smoking ; Smoking cessation ; Guideline ; Diseases of the respiratory system ; RC705-779 ; Specialties of internal medicine ; RC581-951 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Internal medicine ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
Language	Portuguese
Publishing date	2008-10-01T00:00:00Z
Publisher	Sociedade Brasileira de Pneumologia e Tisiologia
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED